AGIO - Agios Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.00
DETAILS
HIGH:
$50.00
LOW:
$36.00
MEDIAN:
$40.00
CONSENSUS:
$42.00
UPSIDE:
49.25%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 54.0 | 36.5 | 26.8 | 14.2 | 0 | 0 | 117.9 | 94.4 | 43.0 | 69.9 | 59.1 | 65.4 | 25.5 | 25.1 | 21.8 |
| Cost of Revenue | 11.5 | 4.2 | 9.5 | 1.7 | 18.8 | 18.8 | 1.3 | 1.4 | 292.7 | 220.2 | 141.8 | 100.4 | 54.5 | 41.0 | 0 |
| Gross Profit | 42.5 | 32.3 | 17.3 | 12.5 | (18.8) | (18.8) | 116.6 | 93.0 | (249.7) | (150.3) | (82.7) | (35.0) | (29.0) | (15.9) | 21.8 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 334.4 | 301.3 | 288.9 | 279.9 | 257.0 | 211.0 | 410.9 | 341.3 | 292.7 | 220.2 | 141.8 | 100.4 | 54.5 | 41.0 | 31.3 |
| SG&A Expenses | 180.3 | 156.8 | 119.9 | 121.7 | 121.4 | 106.1 | 132.0 | 114.1 | 71.1 | 50.7 | 36.0 | 19.1 | 9.9 | 7.1 | 7.2 |
| Other Expenses | 0 | 0 | 0 | 0 | (18.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 514.6 | 458.1 | 408.8 | 401.6 | 359.6 | 317.1 | 542.9 | 455.5 | 363.8 | 270.9 | 177.8 | 119.5 | 64.4 | 48.1 | 38.5 |
| Operating Income | |||||||||||||||
| Operating Income | (472.1) | (425.7) | (391.5) | (389.0) | (378.4) | (335.9) | (426.3) | (362.5) | (320.8) | (201.0) | (118.7) | (54.1) | (38.9) | (23.0) | (16.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 17.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 56.4 | 48.1 | 33.3 | 12.8 | 0.8 | 6.6 | 14.9 | 16.5 | 6.1 | 2.5 | 1.0 | 0.2 | 0.1 | 0.1 | 0.1 |
| Profitability | |||||||||||||||
| EBITDA | (467.0) | (420.1) | (384.9) | (380.5) | (337.7) | (310.5) | (394.9) | (338.9) | (314.4) | (195.3) | (115.4) | (52.8) | (37.4) | (21.8) | (15.8) |
| EBIT | (472.1) | (425.7) | (391.5) | (389.0) | (356.5) | (329.3) | (411.5) | (346.0) | (320.8) | (201.0) | (118.7) | (54.1) | (38.9) | (23.0) | (16.6) |
| Income Before Tax | (413.8) | 718.0 | (352.1) | (231.8) | (356.5) | (329.3) | (411.5) | (346.0) | (314.7) | (198.5) | (117.7) | (53.9) | (38.8) | (22.9) | (16.5) |
| Income Tax Expense | (1.0) | 44.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.4) | (0.4) | 0.6 | (2.8) | 7.2 |
| Net Income | (412.8) | 673.7 | (352.1) | (231.8) | 1,604.7 | (327.4) | (411.5) | (346.0) | (314.7) | (198.5) | (117.7) | (53.5) | (39.4) | (20.1) | (23.7) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -7.12 | 11.86 | -6.33 | -4.23 | -6.36 | -4.74 | -6.61 | -6.03 | -6.75 | -5.07 | -3.15 | -1.59 | -2.56 | -0.86 | -1.01 |
| EPS (Diluted) | -7.12 | 11.64 | -6.33 | -4.23 | -6.36 | -4.74 | -6.61 | -6.03 | -6.75 | -5.07 | -3.15 | -1.59 | -2.56 | -0.86 | -1.01 |
| Shares Outstanding | 58.0 | 56.8 | 55.7 | 54.8 | 60.4 | 69.0 | 60.0 | 57.4 | 46.6 | 39.1 | 37.4 | 33.7 | 15.4 | 23.4 | 23.4 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 89.1 | 76.2 | 88.2 | 139.3 | 203.1 | 127.4 | 80.9 | 805.4 | 567.8 | 573.6 |
| Short-Term Investments | 765.3 | 817.5 | 688.7 | 643.9 | 816.9 | 445.5 | 483.9 | 0 | 0 | 0 |
| Net Receivables | 10.6 | 4.1 | 2.8 | 2.2 | 4.4 | 0 | 15.3 | 10.4 | 3.7 | 8.3 |
| Inventory | 32.9 | 27.6 | 19.1 | 8.5 | 0 | 0 | 7.3 | 0.9 | (143.8) | (32.2) |
| Other Current Assets | 44.1 | 40.2 | 35.0 | 39.0 | 0 | 63.7 | 0 | 17.2 | 0 | 0 |
| Total Current Assets | 942.1 | 965.6 | 833.8 | 832.8 | 1,064.2 | 636.7 | 611.7 | 613.8 | 445.3 | 559.9 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 41.2 | 54.6 | 69.8 | 88.1 | 104.2 | 116.1 | 126.1 | 24.3 | 24.4 | 25.3 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 310.0 | 638.3 | 29.4 | 313.9 | 266.4 | 97.6 | 152.9 | 220.1 | 143.8 | 32.2 |
| Other Non-Current Assets | 3.9 | 4.7 | 4.1 | 4.0 | 2.9 | 2.6 | 0 | 0.2 | 0.9 | 1.6 |
| Total Non-Current Assets | 355.2 | 697.6 | 103.3 | 405.9 | 373.5 | 216.3 | 279.0 | 244.7 | 169.1 | 59.2 |
| Total Assets | 1,297.2 | 1,663.2 | 937.1 | 1,238.7 | 1,437.7 | 853.0 | 890.7 | 858.5 | 614.4 | 619.1 |
| Current Liabilities | ||||||||||
| Account Payables | 18.4 | 16.6 | 9.8 | 18.6 | 16.7 | 17.7 | 21.9 | 17.9 | 22.8 | 17.1 |
| Short-Term Debt | 18.4 | 0 | 0 | 0 | 0 | 7.4 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 10.9 | 92.5 | 163.6 | 190.2 |
| Other Current Liabilities | 18.2 | 46.9 | 23.2 | 12.2 | 19.8 | 48.9 | 19.0 | 22.1 | 18.6 | 24.3 |
| Total Current Liabilities | 82.2 | 81.2 | 68.0 | 62.6 | 59.8 | 94.4 | 92.9 | 93.5 | 94.9 | 88.4 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 21.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (21.7) | 0.9 | 1.2 | 3.3 | 0 | 261.3 | 0 | 17.6 | 18.2 | 17.8 |
| Total Non-Current Liabilities | 21.9 | 41.1 | 58.1 | 75.3 | 85.9 | 359.1 | 157.3 | 77.4 | 144.0 | 172.1 |
| Total Liabilities | 104.1 | 122.2 | 126.1 | 137.9 | 145.8 | 453.5 | 250.2 | 170.9 | 238.9 | 260.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Retained Earnings | (561.7) | (148.9) | (822.6) | (470.6) | (238.8) | (1,843.5) | (1,516.1) | (1,104.6) | (798.1) | (483.2) |
| Accumulated Other Comprehensive Income | 2.2 | (1.5) | (0.4) | (12.5) | (1.2) | 0.1 | 0.2 | (2.2) | (1.4) | (0.3) |
| Total Stockholders' Equity | 1,193.1 | 1,541.0 | 811.0 | 1,100.8 | 1,292.0 | 399.5 | 640.5 | 687.5 | 375.5 | 358.6 |
| Total Liabilities & Equity | 1,297.2 | 1,663.2 | 937.1 | 1,238.7 | 1,437.7 | 853.0 | 890.7 | 858.5 | 614.4 | 619.1 |
| Debt Metrics | ||||||||||
| Total Debt | 62.0 | 57.0 | 72.0 | 85.7 | 97.1 | 105.2 | 113.7 | 0 | 0 | 0 |
| Net Debt | (27.1) | (19.3) | (16.2) | (53.6) | (106.0) | (22.2) | 32.7 | (805.4) | (567.8) | (573.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (412.8) | 673.7 | (352.1) | (231.8) | (356.5) | (329.3) | (411.5) | (346.0) | (314.7) | (198.5) |
| Depreciation & Amortization | 5.2 | 5.7 | 6.6 | 8.6 | 9.2 | 18.8 | 8.1 | 7.2 | 6.4 | 5.7 |
| Stock-Based Compensation | 52.6 | 42.8 | 44.8 | 49.3 | 53.5 | 0 | 72.4 | 73.4 | 47.8 | 42.1 |
| Change in Working Capital | (33.0) | (19.8) | (19.1) | (16.4) | (36.8) | 2.0 | (46.0) | (35.1) | (24.8) | 188.5 |
| Other Non-Cash Items | 15.1 | (1,092.3) | 23.7 | (119.1) | (76.7) | 17.8 | 8.5 | (3.8) | 0.0 | 0.8 |
| Operating Cash Flow | (373.0) | (389.8) | (296.1) | (309.5) | (407.3) | (290.8) | (370.6) | (304.4) | (285.2) | 38.6 |
| Investing Activities | ||||||||||
| Capital Expenditure | (4.3) | (1.7) | (1.0) | (4.9) | (5.7) | (14.1) | (12.2) | (7.0) | (4.6) | (9.9) |
| Acquisitions | 0 | 0.0 | 0 | 132.7 | 0 | 0 | (103.5) | 0 | 0 | 0 |
| Purchases of Investments | (641.8) | (1,542.4) | (417.9) | (1,030.8) | (1,378.2) | (557.0) | (488.6) | (933.3) | (688.7) | (506.1) |
| Sales/Maturities of Investments | 1,033.3 | 818.4 | 674.7 | 1,146.2 | 829.8 | 647.7 | 592.2 | 666.5 | 635.4 | 396.6 |
| Other Investing Activities | (10) | 1,089.1 | (16.2) | 0 | 1,802.9 | (0.8) | 103.5 | (266.8) | (53.3) | (109.4) |
| Investing Cash Flow | 377.2 | 363.4 | 239.6 | 243.3 | 1,248.8 | 75.7 | 91.4 | (273.8) | (57.9) | (119.3) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | (0.3) | (0.6) | (0.3) | (0.1) | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | (802.5) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 37.3 | 250.5 | 12.5 | 29.8 | 14.9 | 7.6 |
| Financing Cash Flow | 8.7 | 14.4 | 5.4 | 2.4 | (765.8) | 261.5 | 289.6 | 546.0 | 285.1 | 169.8 |
| Cash Position | ||||||||||
| Net Change in Cash | 12.9 | (12.0) | (51.1) | (63.9) | 75.7 | 46.5 | 10.4 | (32.2) | (58.0) | 89.0 |
| Cash at Beginning | 76.2 | 88.2 | 139.3 | 203.1 | 127.4 | 80.9 | 70.5 | 102.7 | 160.8 | 71.8 |
| Cash at End | 89.1 | 76.2 | 88.2 | 139.3 | 203.1 | 127.4 | 80.9 | 70.5 | 102.7 | 160.8 |
| Free Cash Flow | (377.3) | (391.5) | (297.1) | (314.4) | (413.1) | (304.9) | (382.8) | (311.4) | (289.9) | 28.6 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 54.0 | 36.5 | 26.8 | 14.2 | 0 | 0 | 117.9 | 94.4 | 43.0 | 69.9 | 59.1 | 65.4 | 25.5 | 25.1 | 21.8 |
| Gross Profit | 42.5 | 32.3 | 17.3 | 12.5 | (18.8) | (18.8) | 116.6 | 93.0 | (249.7) | (150.3) | (82.7) | (35.0) | (29.0) | (15.9) | 21.8 |
| Operating Income | (472.1) | (425.7) | (391.5) | (389.0) | (378.4) | (335.9) | (426.3) | (362.5) | (320.8) | (201.0) | (118.7) | (54.1) | (38.9) | (23.0) | (16.6) |
| Net Income | (412.8) | 673.7 | (352.1) | (231.8) | 1,604.7 | (327.4) | (411.5) | (346.0) | (314.7) | (198.5) | (117.7) | (53.5) | (39.4) | (20.1) | (23.7) |
| EPS (Diluted) | -7.12 | 11.64 | -6.33 | -4.23 | -6.36 | -4.74 | -6.61 | -6.03 | -6.75 | -5.07 | -3.15 | -1.59 | -2.56 | -0.86 | -1.01 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 89.1 | 76.2 | 88.2 | 139.3 | 203.1 | 127.4 | 80.9 | 805.4 | 567.8 | 573.6 | |||||
| Total Assets | 1,297.2 | 1,663.2 | 937.1 | 1,238.7 | 1,437.7 | 853.0 | 890.7 | 858.5 | 614.4 | 619.1 | |||||
| Total Debt | 62.0 | 57.0 | 72.0 | 85.7 | 97.1 | 105.2 | 113.7 | 0 | 0 | 0 | |||||
| Stockholders' Equity | 1,193.1 | 1,541.0 | 811.0 | 1,100.8 | 1,292.0 | 399.5 | 640.5 | 687.5 | 375.5 | 358.6 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (373.0) | (389.8) | (296.1) | (309.5) | (407.3) | (290.8) | (370.6) | (304.4) | (285.2) | 38.6 | |||||
| Capital Expenditure | (4.3) | (1.7) | (1.0) | (4.9) | (5.7) | (14.1) | (12.2) | (7.0) | (4.6) | (9.9) | |||||
| Free Cash Flow | (377.3) | (391.5) | (297.1) | (314.4) | (413.1) | (304.9) | (382.8) | (311.4) | (289.9) | 28.6 | |||||